DK2182988T3 - Radiofarmaceutisk præparat - Google Patents

Radiofarmaceutisk præparat

Info

Publication number: DK2182988T3
Authority: DK; Denmark
Prior art keywords: pharmaceutical preparation; radio pharmaceutical; radio; preparation; pharmaceutical
Prior art date: 2007-08-30

Application number

DK08803301.4T

Other languages

English (en)

Inventor

Line Roed

Sarah Elizabeth Peterson

Original Assignee

Ge Healthcare Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-08-30

Filing date

2008-08-28

Publication date

2014-05-26

2008-08-28 Application filed by Ge Healthcare Ltd filed Critical Ge Healthcare Ltd

2014-05-26 Application granted granted Critical

2014-05-26 Publication of DK2182988T3 publication Critical patent/DK2182988T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0453—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Oil, Petroleum & Natural Gas (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Optics & Photonics (AREA)
Physics & Mathematics (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Dermatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Organic Chemistry (AREA)
Hospice & Palliative Care (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK08803301.4T 2007-08-30 2008-08-28 Radiofarmaceutisk præparat DK2182988T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US96890407P	2007-08-30	2007-08-30
PCT/EP2008/061275 WO2009027452A2 (en)	2007-08-30	2008-08-28	Radiopharmaceutical composition

Publications (1)

Publication Number	Publication Date
DK2182988T3 true DK2182988T3 (da)	2014-05-26

Family

ID=40029249

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK08803301.4T DK2182988T3 (da)	2007-08-30	2008-08-28	Radiofarmaceutisk præparat

Country Status (20)

Country	Link
US (1)	US8916131B2 (da)
EP (1)	EP2182988B1 (da)
JP (1)	JP5367708B2 (da)
KR (1)	KR101571572B1 (da)
CN (1)	CN101790387B (da)
AU (1)	AU2008292201B2 (da)
BR (1)	BRPI0815129B8 (da)
CA (1)	CA2694084C (da)
DK (1)	DK2182988T3 (da)
ES (1)	ES2464715T3 (da)
HU (1)	HUS1500007I1 (da)
IL (1)	IL203316A (da)
MX (1)	MX2010002196A (da)
NO (1)	NO2015006I1 (da)
NZ (1)	NZ583616A (da)
PL (1)	PL2182988T3 (da)
PT (1)	PT2182988E (da)
RU (1)	RU2475267C2 (da)
WO (1)	WO2009027452A2 (da)
ZA (1)	ZA201000718B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL2509637T3 (pl) *	2009-10-08	2016-12-30		Sposób oczyszczania
BR112014024997B1 (pt) *	2012-04-10	2021-03-09	Lantheus Medical Imaging, Inc.	métodos de síntese radiofarmacêutica
US10660966B2 (en)	2014-12-04	2020-05-26	Ge Healthcare Limited	Method for removing acetaldehyde
JP6485914B2 (ja) *	2015-10-28	2019-03-20	日本メジフィジックス株式会社	フルテメタモルの製造方法
JP6955347B2 (ja)	2017-02-28	2021-10-27	日本メジフィジックス株式会社	フルテメタモルの製造方法
CN109400615B (zh) *	2017-08-18	2021-07-16	上海交通大学医学院附属新华医院	一种靶向β-淀粉样蛋白的香豆素类化合物及其制备与应用
US12514525B2 (en) *	2020-03-27	2026-01-06	Jubilant Draximage Inc.	Radiopharmaceutical dispensing systems
KR102207372B1 (ko) *	2020-03-31	2021-01-27	재단법인 아산사회복지재단	방사성 의약품의 안정화제 및 이를 포함하는 방사성 의약 조성물
US11980685B1 (en)	2022-12-23	2024-05-14	Tap Pharmaceuticals, Ag	Liquid pharmaceutical formulations of tafamidis
US11878081B1 (en)	2022-12-23	2024-01-23	Tap Pharmaceuticals Ag	Pharmaceutical formulations of tafamidis

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4335095A (en) *	1979-03-21	1982-06-15	The Radiochemical Centre Limited	Indium-111 oxine complex composition
GB9919673D0 (en) *	1999-08-20	1999-10-20	Cancer Res Campaign Tech	2-Arlybenzazole compounds
ES2395721T3 (es) *	2000-08-24	2013-02-14	University Of Pittsburgh - Of The Commonwealth System Of Higher Education	Derivados de tioflavina y su uso en diagnosis y terapia de la enfermedad de alzheimer
WO2003068269A1 (en) *	2002-02-13	2003-08-21	Amersham Plc	Benzothiazole derivatives for in vivo imaging of amyloid plaques
CA2438032C (en) *	2003-03-14	2013-05-07	University Of Pittsburgh	Benzothiazole derivative compounds, compositions and uses
US20050043523A1 (en) *	2003-08-22	2005-02-24	University Of Pittsburgh	Benzothiazole derivative compounds, compositions and uses
CN102327626A (zh) *	2004-07-02	2012-01-25	匹兹堡大学高等教育联邦体系	诊断淀粉样蛋白沉积相关疾病的前驱形式的方法
SI1771208T1 (sl)	2004-07-02	2013-10-30	University Of Pittsburgh - Of The Commonwealth System Of Higher Education	Uporaba tioflavinskih radioaktivnih derivatov v amiloidnih posnetkih za ocenjevanje proti amiloidnih terapij
JP2008546804A (ja) *	2005-06-24	2008-12-25	ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア	造影剤として用いるためのリガンドの放射性標識ペグ化
GB0516564D0 (en) *	2005-08-12	2005-09-21	Ge Healthcare Ltd	Fluorination process
CA2631905A1 (en) *	2005-12-01	2007-06-07	William E. Klunk	Isotopically-labeled benzothiazole compounds as imaging agents for amyloidogenic proteins
WO2008134618A2 (en)	2007-04-27	2008-11-06	The General Hospital Corporation	Novel imaging tracers for early detection and treatment of amyloid plaques caused by alzheimer's disease and related disorders

2008
- 2008-08-28 ES ES08803301.4T patent/ES2464715T3/es active Active
- 2008-08-28 WO PCT/EP2008/061275 patent/WO2009027452A2/en not_active Ceased
- 2008-08-28 JP JP2010522366A patent/JP5367708B2/ja active Active
- 2008-08-28 KR KR1020107004301A patent/KR101571572B1/ko active Active
- 2008-08-28 DK DK08803301.4T patent/DK2182988T3/da active
- 2008-08-28 NZ NZ583616A patent/NZ583616A/en unknown
- 2008-08-28 PL PL08803301T patent/PL2182988T3/pl unknown
- 2008-08-28 RU RU2010101935/15A patent/RU2475267C2/ru active
- 2008-08-28 CA CA2694084A patent/CA2694084C/en active Active
- 2008-08-28 BR BRPI0815129A patent/BRPI0815129B8/pt active IP Right Grant
- 2008-08-28 EP EP08803301.4A patent/EP2182988B1/en active Active
- 2008-08-28 MX MX2010002196A patent/MX2010002196A/es active IP Right Grant
- 2008-08-28 AU AU2008292201A patent/AU2008292201B2/en active Active
- 2008-08-28 US US12/673,602 patent/US8916131B2/en active Active
- 2008-08-28 PT PT88033014T patent/PT2182988E/pt unknown
- 2008-08-28 CN CN2008801048119A patent/CN101790387B/zh active Active
2010
- 2010-01-14 IL IL203316A patent/IL203316A/en active IP Right Grant
- 2010-01-29 ZA ZA201000718A patent/ZA201000718B/xx unknown
2015
- 2015-02-18 HU HUS1500007C patent/HUS1500007I1/hu unknown
- 2015-02-18 NO NO2015006C patent/NO2015006I1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
US8916131B2 (en)	2014-12-23
JP2010536931A (ja)	2010-12-02
IL203316A (en)	2015-02-26
KR20100055440A (ko)	2010-05-26
MX2010002196A (es)	2010-03-18
AU2008292201B2 (en)	2014-09-04
PT2182988E (pt)	2014-05-16
JP5367708B2 (ja)	2013-12-11
BRPI0815129B8 (pt)	2021-05-25
ES2464715T3 (es)	2014-06-03
AU2008292201A1 (en)	2009-03-05
ZA201000718B (en)	2010-10-27
CA2694084A1 (en)	2009-03-05
HK1146710A1 (en)	2011-07-08
KR101571572B1 (ko)	2015-11-24
RU2475267C2 (ru)	2013-02-20
BRPI0815129B1 (pt)	2021-01-12
PL2182988T3 (pl)	2015-02-27
RU2010101935A (ru)	2011-10-10
CN101790387A (zh)	2010-07-28
WO2009027452A3 (en)	2009-09-03
NZ583616A (en)	2012-06-29
CA2694084C (en)	2015-07-07
EP2182988B1 (en)	2014-04-16
BRPI0815129A2 (pt)	2015-02-03
NO2015006I2 (da)	2015-02-18
US20110008254A1 (en)	2011-01-13
CN101790387B (zh)	2013-03-20
WO2009027452A2 (en)	2009-03-05
NO2015006I1 (no)	2015-03-02
EP2182988A2 (en)	2010-05-12
HUS1500007I1 (hu)	2021-05-07

Publication	Publication Date	Title
LTPA2018005I1 (lt)	2018-02-12	Farmacinė kompozicija
BRPI0807453A2 (pt)	2014-05-20	Preparação sólida
BRPI0721651A2 (pt)	2014-04-01	Composição farmacêutica
BRPI0820381A2 (pt)	2015-05-19	Formulações farmacêuticas
BRPI0920521A2 (pt)	2018-01-16	combinação farmacêutica
DK3492069T3 (da)	2022-03-14	Farmaceutiske sammensætninger omfattende jern-oxy-hydroxid
FI20095373L (fi)	2009-04-06	Antenni
SMT201400069B (it)	2014-07-07	Formulazione farmaceutica
DK2125048T3 (da)	2014-10-13	Præparat
DK2120884T3 (da)	2011-02-07	Farmaceutisk sammensætning
BRPI0807078A2 (pt)	2014-04-08	Composto, e, formulação farmacêutica
DK2182988T3 (da)	2014-05-26	Radiofarmaceutisk præparat
BRPI0921654A2 (pt)	2016-02-10	formulação farmacêutica
DK2285413T3 (da)	2012-08-27	Farmaceutisk sammensætning
PT2209464E (pt)	2014-09-05	Composição farmacêutica antimalárica
BRPI0921313A2 (pt)	2015-12-29	composição farmaucêutica
BRPI0922653A2 (pt)	2016-01-05	preparação farmacêutica
EP2197448A4 (en)	2010-11-17	dosing schedule
DK2271618T3 (da)	2014-06-16	Farmaceutiske forbindelser
BRPI0820198A2 (pt)	2019-09-24	composições farmacêuticas
BRPI0912171A2 (pt)	2017-10-31	composição farmacêutica
FI20075275A0 (fi)	2007-04-19	RF-transkonduktanssituloaste
BRPI0912656A2 (pt)	2016-01-26	formulação farmacêutica sólida
BRPI0921301A2 (pt)	2015-12-29	composição farmacêutica
EP2156832A4 (en)	2010-11-24	PHARMACEUTICAL COMPOSITION